Physician profile
James D Decker
NPI 1295834950
$681.11
in general payments reported to CMS, 2019-2025
21 companies · $112 in 2025
The $112 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $40.64 · 2020: $118 · 2021: $190 · 2022: $73.95 · 2023: $41.41 · 2024: $105 · 2025: $112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $258.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $258.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $94.96 | 2020-2025 | Rybelsus, Ozempic |
| Amgen INC. | $94.43 | 2019-2024 | Evenity, Prolia |
| Lilly USA, LLC | $87.15 | 2020-2023 | Mounjaro |
| Abbvie INC. | $62.59 | 2021-2022 | |
| Sanofi Pasteur INC. | $50.26 | 2024-2025 | |
| Mylan Specialty L.P. | $38.01 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $25.15 | 2024 | |
| Xeris Pharmaceuticals, INC. | $24.96 | 2021 | |
| Abbott Laboratories | $24.52 | 2025 | Freestyle Libre 3 |
| Viatris Specialty LLC | $20.08 | 2025 | Yupelri |
| Edwards Lifesciences Corporation | $19.00 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $18.83 | 2024 | Austedo Xr |
| Allergan, INC. | $17.25 | 2020 | |
| Sunovion Pharmaceuticals INC. | $17.25 | 2019 | |
| Dexcom, INC. | $16.79 | 2025 | Dexcom Stelo Glucose Biosensor, Dexcom G7 Gss (161) |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $16.61 | 2021 | |
| Pfizer INC. | $13.83 | 2025 | |
| Paratek Pharmaceuticals, INC. | $13.69 | 2023 | Nuzyra |
| Merck Sharp & Dohme LLC | $12.15 | 2020 | |
| Collegium Pharmaceutical, INC. | $12.07 | 2019 | |
| Organon LLC | $1.53 | 2025 | Jada System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Decker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.